No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group

MeSH terms

• Acute Disease
• Adult
• Antineoplastic Agents / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Communicable Diseases / complications
• Communicable Diseases / therapy*
• Cytarabine / administration & dosage
• Cytarabine / analogs & derivatives
• Daunorubicin / administration & dosage
• Granulocyte Colony-Stimulating Factor / adverse effects
• Granulocyte Colony-Stimulating Factor / therapeutic use*
• Humans
• Leukemia, Myeloid / complications
• Leukemia, Myeloid / drug therapy*
• Mercaptopurine / administration & dosage
• Prednisolone / administration & dosage
• Recombinant Proteins / therapeutic use*
• Recurrence
• Remission Induction
• Survival Analysis
• Time Factors
• Vincristine / administration & dosage